Dong M, Wang Y, Hadac E M, Pinon D I, Holicky E, Miller L J
Center for Basic Research in Digestive Diseases, Departments of Internal Medicine and Biochemistry/Molecular Biology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
J Biol Chem. 1999 Jul 2;274(27):19161-7. doi: 10.1074/jbc.274.27.19161.
Photoaffinity labeling is a powerful tool for the characterization of the molecular basis of ligand binding. We recently used this technique to demonstrate the proximity between a residue within the carboxyl-terminal half of a secretin-like ligand and the amino-terminal domain of the secretin receptor (Dong, M., Wang, Y., Pinon, D. I., Hadac, E. M., and Miller, L. J. (1999) J. Biol. Chem. 274, 903-909). In this work, we have developed another novel radioiodinatable secretin analogue ([Bpa6,Tyr10]rat secretin-27) that incorporates a photolabile p-benzoyl-L-phenylalanine (Bpa) residue into position 6 of the amino-terminal half of the ligand and used this to identify a specific receptor residue proximate to it. This probe specifically bound to the secretin receptor with high affinity (IC50 = 13.2 +/- 2.5 nM) and was a potent stimulant of cAMP accumulation in secretin receptor-bearing Chinese hamster ovary-SecR cells (EC50 = 720 +/- 230 pM). It covalently labeled the secretin receptor in a saturable and specific manner. Cyanogen bromide cleavage of this molecule yielded a single labeled fragment that migrated on an SDS-polyacrylamide gel at Mr = 19,000 that shifted to 10 after deglycosylation, most consistent with either of two glycosylated fragments within the amino-terminal tail. By immunoprecipitation with antibody directed to epitope tags incorporated into each of the two candidate fragments, the most distal fragment at the amino terminus was identified as the domain of labeling. The labeled domain was further refined to the first 16 residues by endoproteinase Lys-C cleavage and by cyanogen bromide cleavage of another receptor construct in which Val16 was mutated to Met. Radiochemical sequencing of photoaffinity-labeled secretin receptor fragments established that Val4 was the specific site of covalent attachment. This provides the first residue-residue contact between a secretin ligand and its receptor and will contribute substantially to the molecular understanding of this interaction.
光亲和标记是一种用于表征配体结合分子基础的强大工具。我们最近使用该技术证明了促胰液素样配体羧基末端一半内的一个残基与促胰液素受体氨基末端结构域之间的接近性(董,M.,王,Y.,皮农,D. I.,哈达克,E. M.,和米勒,L. J.(1999年)《生物化学杂志》274,903 - 909)。在这项工作中,我们开发了另一种新型的可放射性碘化的促胰液素类似物([Bpa6,Tyr10]大鼠促胰液素 - 27),它在配体氨基末端一半的第6位引入了一个光不稳定的对苯甲酰 - L - 苯丙氨酸(Bpa)残基,并利用它来鉴定与之相邻的一个特定受体残基。该探针以高亲和力(IC50 = 13.2 ± 2.5 nM)特异性结合促胰液素受体,并且是携带促胰液素受体的中国仓鼠卵巢 - SecR细胞中cAMP积累的有效刺激剂(EC50 = 720 ± 230 pM)。它以饱和且特异的方式共价标记促胰液素受体。该分子经溴化氰裂解产生一个单一的标记片段,在SDS - 聚丙烯酰胺凝胶上迁移时Mr = 19,000,去糖基化后变为10,这与氨基末端尾巴内的两个糖基化片段中的任何一个最为一致。通过用针对掺入两个候选片段中每一个的表位标签的抗体进行免疫沉淀,确定氨基末端最远端的片段为标记结构域。通过内肽酶Lys - C裂解以及对另一种受体构建体(其中Val16突变为Met)进行溴化氰裂解,将标记结构域进一步细化到前16个残基。对光亲和标记的促胰液素受体片段进行放射化学测序确定Val4是共价连接的特定位点。这提供了促胰液素配体与其受体之间的首个残基 - 残基接触,并将极大地有助于对这种相互作用的分子理解。